Spero Therapeutics Non-Current Deferred Liabilities (Quarterly) Trends

Spero Therapeutics, Inc. (SPRO)

2.26 -0.04 (-1.74%) USD | NASDAQ | Feb 23, 10:29

View Non-Current Deferred Liabilities (Quarterly) for SPRO.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Non-Current Deferred Liabilities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Non-Current Deferred Liabilities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Non-Current Deferred Liabilities (Quarterly) Benchmarks

Start Trial

BioMarin Pharmaceutical, Inc.	--
Amicus Therapeutics, Inc.	--
Cassava Sciences, Inc.	--
Alpha Teknova, Inc.	Upgrade
Pyxis Oncology, Inc.	--